Current Advances in Osteosarcoma. Questo articolo non è disponibile.
Lingua: inglese
Editore: Palgrave Macmillan, 2016
Serie: Libro 26 di 490 - Advances in Experimental Medicine and Biology
- Brossura
- Nuovo

Da: AHA-BUCH GmbH, Einbeck, GermaniaAHA-BUCH GmbH
Venditore AbeBooks dal 14 agosto 2006
Condizione: Nuovo
EUR 196,75
Descrizione dell’articolo da parte del venditore
nach der Bestellung gedruckt Neuware - Printed after ordering - Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer.It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposednovel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, whichwillhelpmove the fieldforward.…
Codice articolo 9783319344591
- Titolo
- Current Advances in Osteosarcoma
- Autore
- M. D. Kleinerman
- Editore
- Palgrave Macmillan
- Anno di pubblicazione
- 2016
- Condizione
- Neu
- Rilegatura
- Taschenbuch
- Lingua
- inglese
- ISBN 10
- 3319344595
- ISBN 13
- 9783319344591
- Peso dell'articolo
- 569 grammi
- Dimensioni
- 235x155x21 mm
- Serie
- Libro 26 di 490: Advances in Experimental Medicine and Biology
Current Advances in Osteosarcoma edited by Dr. Eugenie S. Kleinerman summarizes molecular and genetic characteristics, new therapeutic ideas, and biological characteristics that have been uncovered in the past 10 years. Osteosarcoma is an aggressive malignant neoplasm and it is also the most common histological form of bone cancer. It accounts for approximately 56% of new bone tumors, making it the most primary malignant bone tumor in children and adolescents. The lungs are the most common site of metastases and once osteosarcoma spreads to the lungs, it is very difficult to treat. To improve the outcome of this disease, the biology of osteosarcoma needs to be better understood. There are numerous investigators around the world who have made seminal discoveries about the important molecular pathways and genetic alterations that contribute to the development and metastases of osteosarcoma. Other investigators have proposed novel therapeutic strategies including some based on the molecular and genetic phenotype of the disease. Current Advances in Osteosarcoma summarizes all of these new discoveries in one singular text, which will help move the field forward.
"Riassunto" può appartenere a un’altra edizione di questo titolo.
Informazioni sull’autore
"Descrizione articolo" può appartenere a un’altra edizione di questo titolo.